• Have a question?
    Open from 8am to 7pm Monday to Friday    Call customer services
    0345 54 32 600


| Print

Xencor (XNCR)

Common Shares
Sell: $15.79|Buy: $15.80|Change: 0.76 (-4.56%)

This share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPP

Company profile

Xencor Inc a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab, and XmAb657. The group earns its revenue from collaboration agreements, product licensing agreements, and technology licensing agreements.

Address

111 West Lemon Avenue
Monrovia
CA
USA
91016

Telephone

+1 626 3055900

Website

https://www.xencor.com

Sector 

Healthcare

Forecast key dates

NameKey Date
Xencor Inc Third Quarter Earnings Results for 20262026-11-05T00:00:00
Xencor Inc Second Quarter Earnings Results for 20262026-08-06T00:00:00
Xencor Inc Annual General Meeting for 20262026-06-12T13:00:00
Xencor Inc First Quarter Earnings Results for 20262026-05-07T00:00:00
Xencor Inc Annual Report for 20252026-02-27T00:00:00
Xencor Inc Fourth Quarter Earnings Results for 20252026-02-27T00:00:00
Piper Sandler 37th Annual Healthcare Conference2025-12-02T14:00:00

Previous key dates

NameKey Date
Piper Sandler 37th Annual Healthcare Conference2025-12-02T14:00:00
TD Cowen Immunology and Inflammation Virtual Summit2025-11-12T15:00:00
Xencor Inc Third Quarter Earnings Results for 20252025-11-05T00:00:00
Xencor XmAb819 Phase 1 Initial Results Webcast2025-10-24T13:30:00
Xencor XmAb819 Phase 1 Initial Results Webcast2025-10-24T13:30:00
Cantor Global Healthcare Conference 20252025-09-04T08:00:00
2025 Wells Fargo Healthcare Conference2025-09-03T15:00:00
Xencor Inc Second Quarter Earnings Results for 20252025-08-06T00:00:00
Xencor Inc Annual General Meeting for 20252025-06-12T13:00:00
Xencor Inc First Quarter Earnings Results for 20252025-05-07T00:00:00
Leerink Partners Global Healthcare Conference2025-03-11T14:20:00
TD Cowen 45th Annual Health Care Conference2025-03-04T11:10:00
Xencor Inc Fourth Quarter Earnings Results for 20242025-02-27T00:00:00
Xencor Inc Annual Report for 20242025-02-27T00:00:00
7th Annual Evercore HealthCONx Conference2024-12-04T15:50:00
Piper Sandler 36th Annual Healthcare Conference2024-12-03T14:00:00

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2025 AJ Bell. All rights reserved.